Adverum Biotechnologies
ADVM
ADVM
83 hedge funds and large institutions have $208M invested in Adverum Biotechnologies in 2019 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 26 increasing their positions, 22 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
3% less funds holding
Funds holding: 86 → 83 (-3)
21% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 14
Holders
83
Holding in Top 10
1
Calls
$194K
Puts
$4K
Top Buyers
| 1 | +$6.51M | |
| 2 | +$6.25M | |
| 3 | +$4.82M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.46M |
| 5 |
JP Morgan Chase
New York
|
+$1.95M |
Top Sellers
| 1 | -$7.82M | |
| 2 | -$2.65M | |
| 3 | -$2.08M | |
| 4 |
Two Sigma Investments
New York
|
-$1.04M |
| 5 |
PA
Perceptive Advisors
New York
|
-$960K |